Clinical Trials at Nationwide Children's Hospital
As of August 2026, 170 paid clinical trials are recruiting at Nationwide Children's Hospital, located at 700 CHILDRENS DR, COLUMBUS, OH 43205-2696, phone (614) 355-2103 in Columbus, Ohio. Active studies at this site cover conditions such as Acute Myeloid Leukemia, Breast Cancer and Chronic Lymphocytic Leukemia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Columbus
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
174 clinical trials at Nationwide Children's Hospital
·Clear filters·A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Pompe Disease Registry Protocol
Fabry Disease Registry & Pregnancy Sub-registry
A Study to Assess Growth in Children With Idiopathic Short Stature
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Child and Adolescent Registry for Participants With Narcolepsy
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
REVEAL: A Phase 3 Study of Obudanersen (ION582) in Angelman Syndrome
4D-710 in Adult Patients With Cystic Fibrosis
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
Study of Olutasidenib and Temozolomide in HGG
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
Minima Stent System Post- Approval Study (PAS)
A Multicenter Multinational Observational Study of Children With Hypochondroplasia
Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
Infant Formula in Infants and Children With Cow's Milk Allergy
Growth and Tolerance of Plant-based Enteral Formulas in Children Ages 12-17 Months.
Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure
NXT Post-Market Clinical Follow-up
Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients
Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy
Teenthrive 2: Treatments for Improving Mood in Teens
Study to Enable New Diagnostics for Pulmonary Microbes in People With CF
Bowel Continence Across the Lifespan in People With Spina Bifida
Feasibility of Light Therapy in the Pediatric Intensive Care Unit (ICU)
Pathways to Prevention Food-is-Medicine Trial
A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
Common conditions studied in Columbus
- Acute Myeloid Leukemia (20 active studies)
- Breast Cancer (19 active studies)
- Chronic Lymphocytic Leukemia (18 active studies)
- Ovarian Cancer (17 active studies)
- Endometrial Cancer (16 active studies)
- Malignant Solid Neoplasm (14 active studies)
Leading research sponsors in Columbus
- Ohio State University
- Ohio State University Comprehensive Cancer Center
- National Cancer Institute (NCI)
- Nationwide Children's Hospital
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Columbus?
There are approximately 1,365 recruiting clinical trials in Columbus, Ohio listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Columbus pay participants?
Most recruiting trials in Columbus compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Columbus?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Columbus?
The most common conditions under active study in Columbus include Acute Myeloid Leukemia (20), Breast Cancer (19), Chronic Lymphocytic Leukemia (18), Ovarian Cancer (17), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Columbus?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Columbus on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Columbus?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Columbus?
Recruiting research sites in Columbus include Ohio State University Comprehensive Cancer Center, Nationwide Children's Hospital, The Ohio State University, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Columbus right now?
The largest active categories in Columbus are Cancer & tumors (492), Cardiovascular (79), Neurology & pain (65). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Nationwide Children's Hospital?
Nationwide Children's Hospital is located at 700 CHILDRENS DR, COLUMBUS, OH 43205-2696. Use the Google Maps link in the intro above to get directions.
How do I contact Nationwide Children's Hospital?
You can reach Nationwide Children's Hospital by phone at (614) 355-2103. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.